RECURRENT INFLAMMATORY BREAST CARCINOMA

Clinical trials for RECURRENT INFLAMMATORY BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT INFLAMMATORY BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT INFLAMMATORY BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New immune therapy tested to keep aggressive breast cancer in check

Disease control Ongoing

This study tested whether the immunotherapy drug pembrolizumab could help control advanced inflammatory or triple-negative breast cancer in patients whose disease had already responded to or stabilized with chemotherapy. The trial involved 71 participants with these aggressive fo…

Matched conditions: RECURRENT INFLAMMATORY BREAST CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

RECURRENT INFLAMMATORY BREAST CARCINOMA

Get alerted when new RECURRENT INFLAMMATORY BREAST CARCINOMA trials appear

New immune therapy tested to keep aggressive breast cancer in check